
Ajay Nooka, MD, MPH
@ajaynookamd
Professor Dept. Hematology/Oncology @EmoryMedicine, #multiplemyeloma and #BMT specialist @WinshipAtEmory. #mmsm Opinions=my own.
ID: 834770831918190592
https://winshipcancer.emory.edu/ajay-nooka 23-02-2017 14:24:10
181 Tweet
2,2K Takipçi
383 Takip Edilen


🆕 #MMUpdate series 1️⃣ evt.to/asiuhohaw 💬 CARTITUDE-2 Trial Updated Results 👥 Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰, Joshua Richter, MD, FACP, & Ajay Nooka, MD, MPH 2️⃣ evt.to/asiuhhshw 💬 PERSEUS Trial Insights from ASH 👥 C. Ola Landgren, M.D., Joshua Richter, MD, FACP, & Ajay Nooka, MD, MPH


Shrinking the divide: improving myeloma CART access Sagar Lonial MD Winship Cancer Institute of Emory University International Myeloma Foundation Multiple Myeloma RF Krina Patel - Peres et al provides the real world evidence of CART In minorities pubmed.ncbi.nlm.nih.gov/38194242/

Winship Cancer Institute of Emory University Sagar Lonial MD Jonathan Kaufman, MD the honor to have a drink from that king glass at Sagar home happens when you hit an important career mile stone. Congratulations my friend - you are an associate professor



Winship Cancer Institute of Emory University Emory University Suresh S. Ramalingam, MD, FASCO Kimberly F Kerstann happy clinical trials day! Time for introspection why we do clinical research! Kudos to all CTO staff at Winship


Thrilled to share that I have accepted a myeloma faculty position Winship Cancer Institute of Emory University Emory University starting fall 2024! Looking forward to working with Sagar Lonial MD Ajay Nooka, MD, MPH Jonathan Kaufman, MD Madhav Dhodapkar Craig Hofmeister Dr. Boise, Dr. Joseph, Dr. Gupta! #mmsm #onwardsandupwards


Sagar Lonial MD Winship Cancer Institute of Emory University Emory University Emory School of Medicine this paper by Dr Joseph is not only practice changing manuscript but a very important milestone for me personally! My first century partnership with Sagar! More to come!!


Winship Cancer Institute of Emory University Jonathan Kaufman, MD Patient care never gets compromised wherever you are, at IMS Brazil


Congratulations Sagar Lonial MD on the richly deserved Bart Barlogie Award! You are an inspiration! #IMS2024


Winship Cancer Institute of Emory University Jonathan Kaufman, MD Sagar Lonial MD Dr Joseph presenting the benefit of quadruplet induction and transplant in pts >65


Madhav Dhodapkar presenting immune micro environment in MGUS at ESH chaired by Bruno Paiva Suzanne Lentzsch, MD, PhD Martin Kaiser Winship Cancer Institute of Emory University Emory University


Winship Cancer Institute of Emory University Emory University this flock of different birds represents hope! Wife of one of my patients with high-risk myeloma on my KPd maintenance clinical trail promised to paint a bird every holiday season that he is alive! I need a bigger desk


Winship Cancer Institute of Emory University Emory University Ms Hernandez-Aldama giving an inspirational personal story of battling 2 cancers to the CTO staff - signifying diversity in clinical trials


Winship Cancer Institute of Emory University Emory University Sara Scott, PharmD, BCOP this is why we do what we do! Eternally grateful for the care that you give Rachael, Joel, Sara, Rosie and Shelley



Excited to welcome Winship Cancer Institute of Emory University into the growing Ryght Global Research Network - very much looking forward to working with Suresh S. Ramalingam, MD, FASCO Ajay Nooka, MD, MPH and colleagues to expedite clinical trial processes using generative AI technology. webwire.com/ViewPressRel.a…

1/ Legend* has it that one can predict bsAb efficacy in #MMsm after a single dose… * No longer a legend! Cool Journal of Clinical Investigation piece by Duffy Madhav Dhodapkar Sagar Lonial MD et al showing ∆ outcomes in myeloma based on CD4 T-cell profiling only 24-48 hrs after 1st tec dose.


Thank you to our outstanding Section Editors and valued partners at Wiley Oncology & Hematology for making this year's ACS Journal Cancer annual meeting a success! We look forward to continuing to bring the best of science to the broadest readership in support of the American Cancer Society mission. 📗
